Protagonist Therapeutics to join the S&P SmallCap 600 Share this:FacebookX Related Post navigation UK economy grew 0.7% in Q1 2024 By Reuters After Nvidia’s stock split and its 150% gain in the first half, will it soar in the second half? This is what the story says